Home/News/News details

Kaposi Sarcoma Market Size, Share, Analysis, Industry Demand and Forecasts Report to 2017

May 19, 2017

Kaposi Sarcoma Market Size, Share, Analysis, Industry Demand and Forecasts Report to 2017

Kaposi sarcoma (KS) or Kaposi's sarcoma or is a malignant tumor caused by infection with human herpes virus 8 (HHV8), also known as KS agent. The disease was originally described in 1872 by a Hungarian dermatologist Moritz Kaposi, practicing at the University of Vienna. By 1980s, it was widely known as one of the Acquired Immuno Deficiency Syndrome (AIDS) -defining illnesses. The viral cause of Kaposi sarcoma was discovered in 1994.

Get Discount on this Report @ https://www.qyresearchgroups.com/check-discount/365995

The disease presents with erythematous to violaceous cutaneous lesions with or without internal disorders. The systemic disease has 4 subtypes-

  • African endemic KS- it was originally found in African men of Sub Saharan origin and now present all over the world. It presents in 2 types- African lymphadenopathic Kaposi sarcoma, which affects children under 10 years of age and aggressively involves the lymph nodes; African cutaneous Kaposi sarcoma, which affects mostly men between 20 to 50 years of age and consists of infiltrative, nodular, vascular masses specially on the extremities.
  • Classic KS, affecting middle aged or elderly men who are of Mediterranean, Arabian, Eastern European descent; it occurs most commonly on the soles and toes as violaceous, reddish, or bluish-black macules and patches which spread and get coalesced to form plaques or nodules. Some of these patients may have lesions on their visceras.In most cases surgery is the only option.
  • KS in iatrogenically immunosuppressed patients- The tumor is caused either when an HHV 8-infected organ is transplanted into a otherwise healthy human or someone when the transplant recipient already has pre-existing HHV 8 infection.
  • HIV/AIDS-related KS

The KS lesions may be solitary, localized or disseminated and can involve lymph nodes, oral cavity, and / or viscera. Its morphology may vary- patch, plaque, macular, nodular, and exophytic.

The African endemic KS and HIV/AIDS-related KS are usually more aggressive. The AIDS-related KS lesions most often rapidly develop and progress to nodules or plaques and affect the face, upper trunk, and oral mucosa. The diagnosis is made with the help of a tissue biopsy and CT Scan/MRI.

Treatment is based on the symptomatology and extent of the disease.  Localized cutaneous lesions are treated with intralesional injections of alitretinoin gel or vinblastine, cryotherapy, radiotherapy, topical immunotherapy with Imiquimod, or surgical excision. Internal disease or extensive cutaneous disease may require immunotherapy or intravenous chemotherapy. In case of iatrogenic immunosuppression related KS, the immunosuppressive therapy should be reduced or discontinued. In AIDS-related KS, highly active antiretroviral therapy (HAART) has been seen to be beneficial.

Ask for Sample copy @ https://www.qyresearchgroups.com/request-sample/365995

Some Points From TOC 

1 Kaposi Sarcoma Market Overview
1.1 Product Overview and Scope of Kaposi Sarcoma
1.2 Kaposi Sarcoma Segment by Type (Product Category)
1.2.1 Global Kaposi Sarcoma Production and CAGR (%) Comparison by Type (Product Category) (2012-2022)
1.2.2 Global Kaposi Sarcoma Production Market Share by Type (Product Category) in 2016
1.2.3 HAART
1.2.4 Chemotherapy
1.2.5 Immunotherapy
1.3 Global Kaposi Sarcoma Segment by Application
1.3.1 Kaposi Sarcoma Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Kaposi Sarcoma Market by Region (2012-2022)
1.4.1 Global Kaposi Sarcoma Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Kaposi Sarcoma (2012-2022)
1.5.1 Global Kaposi Sarcoma Revenue Status and Outlook (2012-2022)
1.5.2 Global Kaposi Sarcoma Capacity, Production Status and Outlook (2012-2022)

Pre Order Enquiry: https://www.qyresearchgroups.com/send-an-enquiry/365995

3 Global Kaposi Sarcoma Capacity, Production, Revenue (Value) by Region (2012-2017)
3.1 Global Kaposi Sarcoma Capacity and Market Share by Region (2012-2017)
3.2 Global Kaposi Sarcoma Production and Market Share by Region (2012-2017)
3.3 Global Kaposi Sarcoma Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Kaposi Sarcoma Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Kaposi Sarcoma Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Kaposi Sarcoma Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Kaposi Sarcoma Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Kaposi Sarcoma Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Kaposi Sarcoma Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Kaposi Sarcoma Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

6 Global Kaposi Sarcoma Market Analysis by Application
6.1 Global Kaposi Sarcoma Consumption and Market Share by Application (2012-2017)
6.2 Global Kaposi Sarcoma Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

Read More: https://www.qyresearchgroups.com/report/global-kaposi-sarcoma-market-research-report-2017

About Us:

QY Research Groups is a company that simplifies how analysts and decision makers get industry data for their business. Our unique colossal technology has been developed to offer refined search capabilities designed to exploit the long tail of free market research whilst eliminating irrelevant results. QY Research Groups is the collection of market intelligence products and services on the Web. We offer reports and update our collection daily to provide you with instant online access to the world's most complete and current database of expert insights on global industries, companies, products, and trends.

Contact us:

Email- sales@qyresearchgroups.com

Web- https://www.qyresearchgroups.com

Follow Us:

LinkedIn | Twitter| Facebook

 

footer pattern

All Copyrights reserve worldhealthcarenews.biz 2017.